Clinical Edge Journal Scan

Laparoscopic gastrectomy is safe in the elderly


 

Takeaway: Laparoscopic vs. open gastrectomy (LG vs. OG) is associated with a lower complication rate and higher survival in elderly patients (age ≥ 80 years) with gastric cancer.

Major finding: Elderly patients who received LG vs. OG had lower blood loss (40 vs. 240 g; P < .01) and incidence of overall postoperative complications (29% vs. 53%; P < .05). The 5-year disease-specific survival rate was significantly higher in the LG vs. OG elderly group (93% vs. 78%; P < .05). Elderly vs. nonelderly patients who received LG had a significantly lower 5-year overall survival rate (67% vs. 87%; P < .01).

Study details: This retrospective study included patients with gastric cancer who received curative gastrectomy between 2003 and 2015 and were divided into three groups, elderly patients who received LG (n = 45) and OG (n = 43) and nonelderly patients who received LG (n = 329).

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Ueda Y et al. Technical and oncological safety of laparoscopic gastrectomy for gastric cancer in elderly patients ≥ 80 years old. BMC Geriatr. 2022;22:475 (Jun 2). Doi: 10.1186/s12877-022-03180-7

Recommended Reading

CRC with synchronous liver metastases: Outcomes of simultaneous laparoscopic vs. hybrid and open resection
MDedge Hematology and Oncology
Does high consumption of nuts and legumes protect against CRC?
MDedge Hematology and Oncology
Obesity and metabolic syndrome at younger ages may increase earlier-onset CRC risk
MDedge Hematology and Oncology
Multi-agent vs. single-agent adjuvant chemotherapy in elderly patients with stage III colon cancer
MDedge Hematology and Oncology
Advanced gastric cancer: Ramucirumab-irinotecan combo fails phase 2
MDedge Hematology and Oncology
Gastric cancer: Tumor mutational burden and outcomes with pembrolizumab
MDedge Hematology and Oncology
Is there a link between tea consumption and gastric cancer?
MDedge Hematology and Oncology
Metastatic gastric cancer: CD163+ macrophage infiltration is a prognostic biomarker
MDedge Hematology and Oncology
Gastric cancer: What is the optimal surgical strategy in the elderly?
MDedge Hematology and Oncology
Gastric cancer: Epstein-Barr virus and H. pylori coinfection is not prognostic
MDedge Hematology and Oncology